Southampton is part of the national effort to prevent, diagnose and treat COVID-19.

We are delivering the national priority COVID-19 research studies, leading several – you can find a list of our COVID-19 studies here.

We will continue to protect vulnerable patients in our cancer and other specific studies, whilst maintining other studies where possible and re-deploying  people and resources to the clinical frontline as needed.

In order to do this, the UHS R&D department is reducing the range of studies it supports until further notice – full details for investigators and staff can be found here.

Participants’ safety is our overriding priority - if you are currently in a research study and have any concerns about how this will affect you, please contact a member of your study team. You will find their details on your study information sheet.